This study was performed to compare patient outcomes after Reamer-Irrigator-Aspirator (RIA)-harvested bone grafting with the current gold standard, either anterior or posterior iliac crest bone graft (ICBG).
Design: Prospective randomized controlled trial.
Setting: Multicenter study at 3 geographically separate Level 1 trauma centers.
Patients: 133 patients with nonunion or posttraumatic segmental bone defect requiring operative intervention.
Intervention: Patients were prospectively randomized to receive ICBG or RIA autograft. Supplemental internal fixation was performed per surgeon preference.
Main Outcome Measures:
When compared with autograft obtained from the iliac crest, autograft harvested using the RIA technique achieves similar union rates with significantly less donor-site pain. RIA also yields a greater volume of graft compared with anterior ICBG and has a shorter harvest time compared with posterior ICBG. For larger volume harvests, cost analysis favors using RIA.
Level of evidence: Therapeutic Level I. Copyright remains with the authors and publisher.
This study was performed to compare patient outcomes after Reamer-Irrigator-Aspirator (RIA)-harvested bone grafting with the current gold standard, either anterior or posterior iliac crest bone graft (ICBG).
Design: Prospective randomized controlled trial.
Setting: Multicenter study at 3 geographically separate Level 1 trauma centers.
Patients: 133 patients with nonunion or posttraumatic segmental bone defect requiring operative intervention.
Intervention: Patients were prospectively randomized to receive ICBG or RIA autograft. Supplemental internal fixation was performed per surgeon preference.
Main Outcome Measures:
When compared with autograft obtained from the iliac crest, autograft harvested using the RIA technique achieves similar union rates with significantly less donor-site pain. RIA also yields a greater volume of graft compared with anterior ICBG and has a shorter harvest time compared with posterior ICBG. For larger volume harvests, cost analysis favors using RIA.
Level of evidence: Therapeutic Level I. Copyright remains with the authors and publisher.